Catyalyst Pharma (CPRX) Tops Q2 EPS by 2c
Get Alerts CPRX Hot Sheet
Price: $14.68 -2.91%
Revenue Growth %: +16.4%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +16.4%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Northeast Community Bancorp, Inc. (NECB) Tops Q1 EPS by 12c
- Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!